.png)
We work with hospitals across regions—grounded in local realities and strengthened by global collaboration—to improve how antimicrobial resistance is understood, managed, and acted on.
Driving Change in Antimicrobial Resistance
"We don't measure our work in features or platforms. We measure it in the clinicians who make better decisions, the hospitals that catch resistance earlier, and the patients who go home."
Real-world evidence
Generated from within hospitals — not in isolation from them.
The work is collaborative, by design.
No single team, technology, or institution can solve antimicrobial resistance alone. Ibhar works alongside clinicians, microbiologists, hospital leaders, researchers, and global health organisations — because the evidence, and the change, has to come from within the system itself.
Global reach, local context
Adapting to the realities of each healthcare system — not applying a single template.
Institutional capacity
Building the skills and systems that last beyond any single program.
Trinity Challenge
Ibhar was selected as a finalist in the Trinity Challenge on Antimicrobial Resistance, a global initiative bringing together experts, organizations, and innovators to develop data-driven solutions addressing AMR. Through this collaboration, Ibhar explored approaches to harness clinical and microbiology data to generate actionable intelligence that supports antimicrobial stewardship and infection prevention across healthcare systems.
UN AIDS HieX
Ibhar’s work in digital health innovation was recognized at the UN AIDS HieX initiative, which highlights impactful health technology solutions that strengthen healthcare systems. This recognition reflects Ibhar’s efforts to develop digital platforms that help healthcare institutions transform operational data into insights that support better clinical decision-making and patient safety.
ICAN Africa
Ibhar collaborates with initiatives such as ICAN Africa to support capacity building in infection prevention and antimicrobial stewardship across healthcare institutions. Through digital tools and collaborative programs, these efforts aim to strengthen surveillance, support clinical teams, and contribute to improving patient safety and infection prevention practices across participating healthcare systems.
AMR Programs
Ibhar has supported antimicrobial stewardship initiatives across hospital networks through collaborative programs involving clinicians, microbiologists, healthcare organizations, and industry partners. These initiatives help hospitals monitor antimicrobial resistance trends, strengthen antibiotic stewardship practices, and generate insights that inform evidence-based policies and clinical decision-making.
Hand Hygiene Study
Ibhar has supported large multi-hospital studies examining hand hygiene compliance and infection prevention practices across healthcare institutions. Insights generated from these studies have helped healthcare teams better understand behavioral patterns, strengthen monitoring mechanisms, and design targeted interventions to improve infection prevention and patient safety.
AMR Research
Through collaborations with hospitals and research partners, Ibhar has contributed to studies analyzing antimicrobial resistance patterns, antibiotic utilization, and stewardship outcomes. Data generated through these initiatives supports clinical research, helps hospitals refine antibiotic policies, and contributes to broader efforts aimed at addressing antimicrobial resistance.
These initiatives collectively contribute to strengthening the global response to antimicrobial resistance by combining clinical collaboration, research insights, and digital intelligence.